TAD
NCT04671511
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer (TADEN)
Status:
Recruiting
Phase
Neoajduvant
Line of Therapy
Early Cancer
Disease Stage
Biomarker(s)
Investigational
Product
n/a
Sentinel node biopsy and clipping and removing node
Treatment Arms
o Targeted Axillary Dissection